Quantum Pharmaceuticals has formed what it says is a promising new partnership with the Pulmonology Research Institute of the Russian Federation Ministry of Health
The Institute is headed by Professor AG Chuchalin - a RAMN Academic and a leading pulmonologist of the Russian Federation. The Institute offers high scientific potential due to its unique methods for diagnoses and treatments of widespread as well as rare serious lung diseases.
It is the leading research organisation of the Russian Ministry of Health on questions of diagnosis, treatment, and prevention of diseases of the respiratory organs.
In this partnership, the institute will provide Quantum Pharmaceuticals with validated targets for various pulmonary diseases.
Quantum will find and synthesise inhibitors for these targets and the institute will conduct in vitro and in vivo testing.
